A
Alto Neuroscience, Inc. (ANRO)
20.50
0.00 (0.00%)
Get all premium features to the best stock analysis tool
20.50
0.00 (0.00%)
No Data
There are no news for this stock.
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 15.69 | 6.05 | 10 | |
| Quick ratio | 15.69 | 5.63 | 10 | |
| Debt to Equity | 0.16 | 0.30 | 9.0 | |
| Debt to Assets | 0.13 | 1.04 | 8.0 | |
| Interest coverage | -29.66 | -16.91 | 1.0 | |
| Weighted average score | 7.6 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | -342K | -373K | -502K | -661K | -592K |
| Operating Income | -29M | -38M | -69M | -66M | -66M |
| Net Income | -28M | -36M | -61M | -63M | -63M |
| EBITDA | -29M | -37M | -68M | -66M | -66M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | N/A | 5.18 | 3.0 |
| Next quarter | N/A | 9.38 | 3.5 |
| Current year | N/A | -9.82 | 1.0 |
| Next year | N/A | -19.81 | 1.0 |
| Weighted average score | 2.1 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 999 | -14.1 | 11.54 | -16.1 | 4.8 |
| Y/Y | 999 | -6.44 | 11.54 | 14.87 | 6.5 |
| 3y average | 999 | -34.37 | 43.36 | -37.02 | 5.5 |
| 5y average | N/A | N/A | N/A | N/A | 1.0 |
| Weighted average score | 4.5 | ||||
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |
Company's cash reserves $176.5M significantly exceed its total debt $24.0M, ensuring strong financial flexibility
Total current assets $177.7M exceed Total current liabilities $11.3M, highlighting excellent liquidity
Debt-to-equity ratio (0.2) is well below the industry average (0.3), showcasing prudent financial management
Interest coverage ratio (-29.7x) is dangerously low, suggesting debt repayment risks
Negative free cash flow -$11.5M limits the company's ability to reinvest or pay down debt